No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors

被引:37
|
作者
Rietbergen, Michelle M. [1 ]
Braakhuis, Boudewijn J. M. [1 ]
Moukhtari, Nadia [1 ]
Bloemena, Elisabeth [2 ,3 ]
Brink, Arjen [1 ]
Sie, Daoud [3 ]
Ylstra, Bauke [3 ]
de Jong, Robert J. Baatenburg [4 ]
Snijders, Peter J. F. [3 ]
Brakenhoff, Ruud H. [1 ]
Leemans, C. Rene [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Erasmus MC, Dept Otolaryngol Head & Neck Surg, Rotterdam, Netherlands
关键词
SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY TUMORS; GENETICALLY ALTERED FIELDS; NECK-CANCER PATIENTS; CLINICAL-IMPLICATIONS; COPY NUMBER; ARRAY CGH; HEAD; CANCERIZATION; PREVALENCE;
D O I
10.1111/jop.12123
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with HPV-negative OPSCCs. Important factors contributing to this better prognosis are relatively low numbers of local/regional recurrences (LRRs) and second primary tumors (SPTs) in patients with HPV-positive OPSCC. These low numbers may be explained in addition by the absence of a 'field cancerization' effect, which is a cause of LRRs and SPTs in patients with HPV-negative OPSCC. We aimed to detect a possible 'field effect' in patients with HPV-positive OPSCC. As HPV is involved in the early stage of carcinogenesis in OPSCCs, its presence is considered a reliable marker for the detection of such a field effect. Therefore, the presence of transcriptionally active HPV was analyzed in the mucosa surrounding HPV-positive OPSCCs. Methods: We included 20 patients who were surgically treated for an HPV-positive OPSCC in the period 2000-2006. Of each patient, the formalin-fixed paraffin-embedded tumor sample and all available resection margins were collected. In total, 97 resection margins were investigated with an average of five resection margins per tumor. All samples were analyzed for the presence of tumor and the presence of transcriptionally active HPV by HPV16-E6-mRNA detection. Results: All tumors were HPV16-E6-mRNA positive. HPV16-E6-mRNA could be detected in the resection margins that contained tumor (n = 6). All tumor-negative resection margins (n = 91) scored negative for HPV16-E6-mRNA. Conclusions: In conclusion, transcriptional active HPV could not be detected in the mucosa surrounding an HPV-positive OPSCC, which suggests the absence of field effect. This observation may explain the lower number of LRRs and SPTs in HPV-positive patients. © 2013 John Wiley & Sons A/S.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [31] The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma
    Sjoblom, Anni
    Carpen, Timo
    Stenman, Ulf-Hakan
    Jouhi, Lauri
    Haglund, Caj
    Syrjanen, Stina
    Mattila, Petri
    Makitie, Antti
    Hagstrom, Jaana
    CANCERS, 2022, 14 (12)
  • [32] History of HPV in HPV-positive elderly women
    Hermansson, Ruth S.
    Lillsunde-Larsson, Gabriella
    Helenius, Gisela
    Karlsson, Mats G.
    Kaliff, Malin
    Olovsson, Matts
    Lindstrom, Annika K.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 22
  • [33] Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women
    Sangrajrang, Suleeporn
    Laowahutanont, Piyawat
    Wongsena, Metee
    Muwonge, Richard
    Imsamran, Weerawut
    Ploysawang, Pattama
    Basu, Partha
    JOURNAL OF MEDICAL SCREENING, 2019, 26 (04) : 212 - 218
  • [34] Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma
    Dalianis, Tina
    PRESSE MEDICALE, 2014, 43 (12): : E429 - E434
  • [35] Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)
    Mrochem-Kwarciak, Jolanta
    Rutkowski, Tomasz
    Wygoda, Andrzej
    Chmura, Aleksandra
    Deja, Regina
    Skladowski, Krzysztof
    ORAL ONCOLOGY, 2021, 118
  • [36] Circulating HPV Tumor DNA and Molecular Residual Disease in HPV-Positive Oropharyngeal Cancers: A Scoping Review
    Migliorelli, Andrea
    Ciorba, Andrea
    Manuelli, Marianna
    Stomeo, Francesco
    Pelucchi, Stefano
    Bianchini, Chiara
    DIAGNOSTICS, 2024, 14 (23)
  • [37] Prevalence of oropharyngeal human papilloma virus (HPV) in women with high-risk HPV-positive CIN 2-3
    Grimm, D. K.
    Breuer, J.
    Meyer, T.
    Teudt, I.
    Brummer, O.
    Prieske, K.
    Schmalfeldt, B.
    Bohlmann, I.
    Woelber, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 22 - 22
  • [38] Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas
    Martinez, Ivan
    Wang, Jun
    Hobson, Kenosha F.
    Ferris, Robert L.
    Khan, Saleem A.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 415 - 432
  • [39] Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review
    Gregoire B. Morand
    Alina Diaconescu
    Iman Ibrahim
    Genevieve Lamarche
    Juliana S. Ruas
    Jacqueline Dalfen
    Michael P. Hier
    Moulay A. Alaoui-Jamali
    Mariana Maschietto
    Sabrina Daniela da Silva
    Clinical & Experimental Metastasis, 2022, 39 : 407 - 416
  • [40] Prognostic significance of cystic nodal metastasis in HPV-positive oropharyngeal cancer
    Pupic-Bakrac, Jure
    Rasic, Mario
    ENT-EAR NOSE & THROAT JOURNAL, 2022,